BeastFitness
Banned
- Awards
- 0
***GW-501516 (Cardarine)***
As requested by someone on my FaceBook page, I wanted to talk a little more about GW-501516 (Cardarine.) Cardarine is a Peroxisome proliferator-activated receptor delta agonist. When looking at a few rat studies, we see the binding of Cardarine to PPARO which recruits the coactivator PGC-1a forming a complex that up regulates the expression of proteins (involved in energy expenditure.) Looking further, we also see Cardarine to:
-increase fatty acid metabolism
-protection against obesity
-increased endurance capabilities
-protection against diabetes.
-increased high-density lipoprotein (HDL) and lowered very-low-density lipoprotein (VLDL).
-increased anti-catabolic properties
As with any compound, its going to have benefits and side effects depending on how an individual metabolizes it and what genetic predispositions are already current. Utilizing a very lose dosage approach pre workout seems to provide consistent and noticeable ergogenic effects.
A metabolomic study of the PPAR
GW501516-activated PPAR
http://www.ajconline.org/article/S0002-9149(07)01592-5/abstract
As requested by someone on my FaceBook page, I wanted to talk a little more about GW-501516 (Cardarine.) Cardarine is a Peroxisome proliferator-activated receptor delta agonist. When looking at a few rat studies, we see the binding of Cardarine to PPARO which recruits the coactivator PGC-1a forming a complex that up regulates the expression of proteins (involved in energy expenditure.) Looking further, we also see Cardarine to:
-increase fatty acid metabolism
-protection against obesity
-increased endurance capabilities
-protection against diabetes.
-increased high-density lipoprotein (HDL) and lowered very-low-density lipoprotein (VLDL).
-increased anti-catabolic properties
As with any compound, its going to have benefits and side effects depending on how an individual metabolizes it and what genetic predispositions are already current. Utilizing a very lose dosage approach pre workout seems to provide consistent and noticeable ergogenic effects.
A metabolomic study of the PPAR
GW501516-activated PPAR
http://www.ajconline.org/article/S0002-9149(07)01592-5/abstract